U.S. Canine Atopic Dermatitis Market Size & Outlook

The canine atopic dermatitis market in the United States is expected to reach a projected revenue of US$ 2,021.2 million by 2030. A compound annual growth rate of 9.2% is expected of the United States canine atopic dermatitis market from 2025 to 2030.
Revenue, 2024 (US$M)
$1,203.7
Forecast, 2030 (US$M)
$2,021.2
CAGR, 2025 - 2030
9.2%
Report Coverage
U.S.

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

U.S. canine atopic dermatitis market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

U.S. canine atopic dermatitis market highlights

  • The U.S. canine atopic dermatitis market generated a revenue of USD 1,203.7 million in 2024 and is expected to reach USD 2,021.2 million by 2030.
  • The U.S. market is expected to grow at a CAGR of 9.2% from 2025 to 2030.
  • In terms of segment, glucocorticoids was the largest revenue generating product in 2024.
  • MAbs is the most lucrative product segment registering the fastest growth during the forecast period.


Canine atopic dermatitis market data book summary

Market revenue in 2024USD 1,203.7 million
Market revenue in 2030USD 2,021.2 million
Growth rate9.2% (CAGR from 2025 to 2030)
Largest segmentGlucocorticoids
Fastest growing segmentMAbs
Historical data2018 - 2023
Base year2024
Forecast period2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationGlucocorticoids, Antihistamines, Immunosuppressants, MAbs
Key market players worldwideZoetis Inc Class A, Merck & Co., Inc., Elanco, Boehringer Ingelheim International GmbH, Virbac SA, Vetoquinol SA, Biofelix Pharma Group, Dechra, Toray Industries Inc, Bioiberica, CEVA Inc, Bimeda


Other key industry trends

  • In terms of revenue, U.S. accounted for 31.2% of the global canine atopic dermatitis market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In North America, U.S. canine atopic dermatitis market is projected to lead the regional market in terms of revenue in 2030.
  • Canada is the fastest growing regional market in North America and is projected to reach USD 505.6 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Canine Atopic Dermatitis Market Companies

Name Profile # Employees HQ Website
Dechra View profile - Shrewsbury, Shropshire, United Kingdom, Europe https://www.dechra.co.uk
Biofelix Pharma Group View profile 11-50 Ahmedabad, Gujarat, India, Asia https://biofelixgroup.com
Boehringer Ingelheim International GmbH View profile - - -
Merck & Co., Inc. View profile - - -
Elanco View profile 10001+ Greenfield, Indiana, United States, North America https://www.elanco.com
Bioiberica View profile 251-500 Barcelona, Catalonia, Spain, Europe https://www.bioiberica.com/
Bimeda View profile 1001-5000 Dublin, Dublin, Ireland, Europe https://www.bimeda.com/
Vetoquinol SA View profile 2483 Magny-Vernois, BP 189, Lure cedex, France, 70204 http://www.vetoquinol.com
Toray Industries Inc View profile 48682 Nihonbashi Mitsui Tower 2-1-1, Nihonbashi Muromach, Chuo-ku, Tokyo, Japan, 103-8666 http://www.toray.co.jp
CEVA Inc View profile 424 15245 Shady Grove Road, Suite 400, Rockville, MD, United States, 20850 https://www.ceva-dsp.com
Virbac SA View profile 5400 2065m LID, 1 ere avenue, Carros, France, 06516 https://www.virbac.com
Zoetis Inc Class A View profile 14100 10 Sylvan Way, Parsippany, NJ, United States, 07054 https://www.zoetis.com

U.S. canine atopic dermatitis market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to canine atopic dermatitis market will help companies and investors design strategic landscapes.


Glucocorticoids was the largest segment with a revenue share of 41.31% in 2024. Horizon Databook has segmented the U.S. canine atopic dermatitis market based on glucocorticoids, antihistamines, immunosuppressants, mabs covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to U.S. canine atopic dermatitis market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of U.S. canine atopic dermatitis market databook

  • Our clientele includes a mix of canine atopic dermatitis market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the U.S. canine atopic dermatitis market , including forecasts for subscribers. This country databook contains high-level insights into U.S. canine atopic dermatitis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

U.S. canine atopic dermatitis market size, by product, 2018-2030 (US$M)

U.S. Canine Atopic Dermatitis Market Outlook Share, 2024 & 2030 (US$M)

U.S. canine atopic dermatitis market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online